Viemed Healthcare reports Q4 2022 core revenue of $37.5M, up 30% YoY; full-year adjusted EBITDA $30.0M

VIEMED HEALTHCARE, INC.

Q4 core net revenue $37.5M (record), +30% vs Q4 2021, +5% sequentially.
Full-year 2022 net revenue $138.8M, including $2.3M COVID-related services.
Q4 net income $2.4M; full-year net income $6.2M.
Adjusted EBITDA Q4 $9.3M; full-year $30.0M.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

VIEMED HEALTHCARE, INC. reported three months and year ended December 31, 2022 results: revenue Net revenues attributable to the Company's core business for the quarter ended December 31, 2022 were $37.5 million...To, net income Net income for the quarter and year ended December 31, 2022 totaled $2.4 million and $6.2 million, respectively.

Period: three months and year ended December 31, 2022
Revenue: Net revenues attributable to the Company's core business for the quarter ended December 31, 2022 were $37.5 million...To
Net income: Net income for the quarter and year ended December 31, 2022 totaled $2.4 million and $6.2 million, respectively
Result: reported results

Exact text from the filing

Net revenues attributable to the Company's core business for the quarter ended December 31, 2022 were $37.5 million

View on SEC.gov

Browse all earnings releases →

VIEMED HEALTHCARE, INC. filing history →

Source: SEC EDGAR

accession 0001729149-23-000039

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.